Post by
Lesalpes29 on Mar 16, 2023 9:48am
Interesting..
The Canadian side is leading the little push today. GL
Comment by
fox7mf on Mar 16, 2023 5:15pm
Not a bad day, perhaps attributable to the supposed absence of the word "potential" before reference to biomarkers in the updated investor presentation. I haven't had a chance to peruse and confirm this, but perhaps we finally have confirmation. GLTA.
Comment by
westcoast1000 on Mar 16, 2023 5:22pm
I reviewed the new presentation and it has much more discussion about CAR-T and pela, IIRC. As always the information is clear and impressive. They do a veyr good job communicating complex science and health questions. However, the term "potential" biomarker is still apparent on page 12.
Comment by
canadafan on Mar 16, 2023 5:30pm
The use of the owrd potential in that context is They may potentially use it. Where-as the previous "potential" was in decription of the "potential" outcome.( of the biomrker accuarcy" I belive. Regardless, they use the word potential a few times further. That being "potential" additional markets ( in wide angle lens terms)
Comment by
megaflop on Mar 16, 2023 5:44pm
A direct quote: Registrational study in HR+/HER2- mBC program Design to be informed by AWARE-1 and Bracelet-1 data including the potential use of T cell clonality as a predictive biomarker